Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
An integrated molecular profile of endometrioid ovarian cancer.
Subset of EOVC cases closely resembled HGSC.
»
08/17/19
Trends in malignant melanoma mortality in 31 countries from 1985 to 2015.
MM mortality greater for males than females in all countries.
»
03/06/20
Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancer.
No dose-limiting toxicities recorded.
»
07/18/19
Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma.
ONC201/TIC10 impairs mitochondrial respiration.
»
06/10/19
Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients.
GJ Ca 72.4 ≥6.49 ng/ml strongly correlated with traditional categories of aggressive cancer.
»
01/28/20
The diagnostic and prognostic roles of serum irisin in bladder cancer.
Serum irisin levels exhibited significantly lower levels in BC patients.
»
06/29/19
Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer?
Genetic variation and homozygosity patterns suggested that gene conversion of this X chromosome associated virus occurred.
»
03/07/20
The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy
TG-186-calculated dose found to be on average lower than dose calculated with TG-43U1.
»
03/09/20
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinum
Comparative planning and considering different risk factors for late morbidity recommended for each patient.
»
03/12/20
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
Incidences of all-grade and grades 3/4 hematologic AEs lower following dose reduction.
»
03/12/20
< Prev
Next >